442 related articles for article (PubMed ID: 26031764)
1. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients.
Hu R; Xu F; Sheng Y; Qi S; Han Y; Miao Y; Rui W; Yang Q
Dermatol Ther; 2015; 28(5):303-8. PubMed ID: 26031764
[TBL] [Abstract][Full Text] [Related]
2. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
4. Oral Finasteride Presents With Sexual-Unrelated Withdrawal in Long-Term Treated Androgenic Alopecia in Men.
Perez-Mora N; Velasco C; Bermüdez F
Skinmed; 2015; 13(3):179-83. PubMed ID: 26380503
[TBL] [Abstract][Full Text] [Related]
5. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
Tanglertsampan C
J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
Khandpur S; Suman M; Reddy BS
J Dermatol; 2002 Aug; 29(8):489-98. PubMed ID: 12227482
[TBL] [Abstract][Full Text] [Related]
8. Multi-therapies in androgenetic alopecia: review and clinical experiences.
Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
[TBL] [Abstract][Full Text] [Related]
9. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
Walsh DS; Dunn CL; James WD
Arch Dermatol; 1995 Dec; 131(12):1373-5. PubMed ID: 7492124
[No Abstract] [Full Text] [Related]
10. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial.
Rossi A; Caro G
J Cosmet Dermatol; 2024 Feb; 23(2):502-509. PubMed ID: 37798906
[TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men.
Tsuboi R; Arano O; Nishikawa T; Yamada H; Katsuoka K
J Dermatol; 2009 Aug; 36(8):437-46. PubMed ID: 19691748
[TBL] [Abstract][Full Text] [Related]
12. Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study.
Alves R; Grimalt R
Dermatol Surg; 2018 Jan; 44(1):126-130. PubMed ID: 28562433
[No Abstract] [Full Text] [Related]
13. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.
Iamsumang W; Leerunyakul K; Suchonwanit P
Drug Des Devel Ther; 2020; 14():951-959. PubMed ID: 32184564
[TBL] [Abstract][Full Text] [Related]
14. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
Tosti A; Iorizzo M; Vincenzi C
Arch Dermatol; 2003 Sep; 139(9):1221-2. PubMed ID: 12975176
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia.
Gupta AK; Talukder M; Shemer A
Expert Opin Pharmacother; 2024 Feb; 25(2):139-147. PubMed ID: 38315101
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
Suchonwanit P; Iamsumang W; Rojhirunsakool S
Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
[TBL] [Abstract][Full Text] [Related]
17. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
18. Frontal fibrosing alopecia: to treat or not to treat?
Rallis E; Gregoriou S; Christofidou E; Rigopoulos D
J Cutan Med Surg; 2010; 14(4):161-6. PubMed ID: 20642984
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Chen L; Zhang J; Wang L; Wang H; Chen B
Aesthetic Plast Surg; 2020 Jun; 44(3):962-970. PubMed ID: 32166351
[TBL] [Abstract][Full Text] [Related]
20. [Androgenetic alopecia: drug treatment].
Granel F
Ann Dermatol Venereol; 2000 Jun; 127 Suppl 1():1S16-20. PubMed ID: 10962364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
